- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 114,390 | 13.08.24 22:00:06 | +0,910 | +0,80% | 114,010 | 114,290 | 113,570 | 113,480 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 103,020 | 13.08.24 22:00:08 | +3,420 | +3,43% | 50,470 | 103,030 | 103,280 | 99,600 |
